Emergent BioSolutions, Inc. (EBS)
11.62
-0.25
(-2.11%)
USD |
NYSE |
Dec 09, 16:00
11.74
+0.12
(+1.03%)
Pre-Market: 08:44
Emergent BioSolutions EPS Diluted (Quarterly): 0.9062 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.9146 |
| SIGA Technologies, Inc. | -0.0889 |
| Tonix Pharmaceuticals Holding Corp. | -3.587 |
| GeoVax Labs, Inc. | -0.3115 |
| Black Diamond Therapeutics, Inc. | -0.1493 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 51.20M |
| Revenue (Quarterly) | 231.10M |
| Total Expenses (Quarterly) | 179.90M |
| Enterprise Value | 1.032B |
| Gross Profit Margin (Quarterly) | 55.86% |
| Profit Margin (Quarterly) | 22.15% |
| Earnings Yield | 11.14% |
| Operating Earnings Yield | 17.97% |
| Normalized Earnings Yield | 10.86 |